Showing results (151-160 of 241) with videos related to

Sort By:
Pageof 25
Blood|December 17, 2009
Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemiaHideki Muramatsu, Hideki Makishima, Anna M Jankowska, et al.
International Journal of Hematology|June 25, 2018
Whole-exome analysis to detect congenital hemolytic anemia mimicking congenital dyserythropoietic anemiaMotoharu Hamada, Sayoko Doisaki, Yusuke Okuno, et al.
Pediatric Transplantation|April 10, 2008
A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemiaMiharu Yabe, Masahiro Sako, Hiromasa Yabe, et al.
Modern Rheumatology|June 9, 2025
Safety of glucocorticoid dose reduction in microscopic polyangiitis: a multicentre REVEAL cohort studyHirofumi Miyake, Takuya Kotani, Shogo Matsuda, et al.
Japanese Journal of Clinical Oncology|July 28, 2018
Secondary bone/soft tissue sarcoma in childhood cancer survivors: a nationwide hospital-based case-series study in JapanYasushi Ishida, Miho Maeda, Souichi Adachi, et al.
International Journal of Hematology|July 5, 2018
Clinical characteristics of pediatric patients with myeloid sarcoma without bone marrow involvement in JapanTakashi Taga, Toshihiko Imamura, Kentaro Nakashima, et al.
Frontiers in Immunology|April 20, 2026
Long-term outcomes remain unchanged despite reduced glucocorticoid exposure in ANCA-associated vasculitis: the multicentre REVEAL cohort studyMayu Shiomi, Ryu Watanabe, Muneyuki Hatta, et al.
Immunological Medicine|November 1, 2024
Increased response to granulocyte-macrophage colony-stimulating factor in peripheral blood cells and transient manifestations mimicking juvenile myelomonocytic leukemia in a male patient with NEMO deficiency caused by a deep intronic pathogenic variant of IKBKGMasahiro Ueki, Shinsuke Hirabayashi, Yoshitaka Honda, et al.
Cancer Science|October 2, 2019
Efficacy of the NCCV Cocktail-1 vaccine for refractory pediatric solid tumors: A phase I clinical trialYu Akazawa, Ako Hosono, Toshiaki Yoshikawa, et al.
Transplantation and Cellular Therapy|October 8, 2023
Allogeneic Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia with a Busulfan, Fludarabine, and Melphalan Regimen: JPLSG JMML-11Kazuo Sakashita, Nao Yoshida, Hideki Muramatsu, et al.
Pageof 25